Genetic Variants in IREB2 and TGF-beta1 and Their Role in COPD
Author Information
Author(s): Sally L Chappell, Leslie Daly, Lotya Juzer, Aiman Alsaegh, Tamar Guetta-Baranes, Josep Roca, Roberto Rabinovich, Kevin Morgan, Ann B Millar, Seamas C Donnelly, Vera Keatings, William MacNee, Jan Stolk, Pieter S Hiemstra, Massimo Miniati, Simonetta Monti, Clare M O'Connor, Noor Kalsheker
Primary Institution: The University of Nottingham
Hypothesis
Are genetic variants in IREB2 and TGF-beta1 associated with susceptibility to COPD?
Conclusion
The study confirmed that IREB2 genetic variants contribute to COPD susceptibility, while no significant associations were found for TGF-beta1.
Supporting Evidence
- The study replicated previous associations of IREB2 SNPs with COPD.
- Significant differences in allele frequencies were found for IREB2 SNPs between cases and controls.
- No significant associations were found for TGF-beta1 SNPs.
Takeaway
This study looked at genes that might make people more likely to get COPD, a lung disease. It found that one gene, IREB2, is linked to the disease, but another gene, TGF-beta1, is not.
Methodology
The study examined genetic variants in 1017 COPD patients and 912 controls, comparing allele and genotype frequencies.
Potential Biases
Potential bias due to population differences and exclusion criteria.
Limitations
The study did not achieve complete matching between cases and controls, which may affect the results.
Participant Demographics
Participants were white Caucasians, including 1017 COPD patients and 912 non-diseased smoking controls.
Statistical Information
P-Value
0.0018, 0.0039, 0.0053
Confidence Interval
1.12, 1.50; 0.64, 0.92; 0.68, 0.91
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website